Sensex Dips Nearly 0.8% as Metal Sector Slumps; Pharma Shines Amid Broad Market Weakness

1 hour ago
share
Share Via
The Indian equity market witnessed a broad-based decline on 23 June 2026, with the Sensex falling 0.76% to close at 76,505.73 amid weak global cues and sectoral pressure. While the metal sector dragged the indices lower, the pharmaceutical sector bucked the trend, hitting fresh 52-week highs. Market breadth remained subdued with a significant number of declines across the BSE500, reflecting cautious investor sentiment.
Sensex Dips Nearly 0.8% as Metal Sector Slumps; Pharma Shines Amid Broad Market Weakness

Sensex and Nifty Performance Overview

The BSE Sensex opened flat with a marginal loss of 8.02 points but soon succumbed to selling pressure, dropping as much as 549.84 points during the session to trade near 76,536.21 (-0.72%). By the close, the index settled at 76,505.73, down 588.34 points or 0.76%. The Nifty mirrored this weakness, pressured by losses in heavyweight sectors. Despite the decline, the Sensex remained above its 50-day moving average (DMA), although the 50DMA itself continues to trade below the 200DMA, signalling a cautious medium-term technical outlook.

Sectoral Trends: Pharma Outperforms, Metals Falter

Out of 38 sectors tracked, only two managed to advance, while 36 sectors declined, underscoring the broad-based weakness. The Nifty Pharma sector was the standout performer, gaining 1.23% and hitting new 52-week highs, supported by robust buying interest in healthcare stocks. Conversely, the metal sector was the worst performer, with the Nifty Metal index plunging 3.21%, weighed down by concerns over global commodity prices and subdued demand outlook.

Market Breadth and Capitalisation Segments

Market breadth was decidedly negative, with the advance-decline ratio across the BSE500 standing at 138 advances against 362 declines, a ratio of just 0.38x. This indicates a strong dominance of sellers across the broader market. The S&P BSE 250 Smallcap index fell 0.4%, while the S&P BSE 150 Midcap index declined 0.54%. The BSE100 index also slipped 0.75%, reflecting weakness across large-cap stocks.

Top Gainers and Losers Across Market Caps

Among large caps, Info Edge (India) emerged as the top gainer, rising 3.37%, buoyed by positive investor sentiment around its digital classifieds business. Meesho led the midcap segment with an impressive 8.06% gain, reflecting renewed optimism in the e-commerce space. The small-cap segment saw Cohance Life surge 13.50%, marking the highest percentage gain across the BSE500.

On the downside, Canara Bank was the largest large-cap loser, dropping 3.11% amid concerns over asset quality and margin pressures. National Aluminium was the top midcap laggard, falling 5.85%, while New India Assurance declined 6.53%, the steepest fall among small caps. Other notable losers included Prime Focus, down 4.99%.

Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!

  • - Recently turned profitable
  • - Strong business fundamentals
  • - Pre-breakout opportunity

Catch the Breakout Early →

Foreign Institutional and Domestic Institutional Activity

Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) remained cautious amid mixed global cues. While detailed net flows are yet to be disclosed, the subdued market breadth and sectoral weakness suggest that FIIs were net sellers or at best neutral, particularly avoiding metal and banking stocks. DIIs likely provided some support in defensive sectors such as pharmaceuticals, which outperformed the broader market.

Global Cues and Their Impact

Global markets were subdued, with concerns over inflationary pressures and geopolitical tensions weighing on investor sentiment. Commodity prices, especially metals, retreated on fears of slowing demand from China and other major economies, impacting Indian metal stocks. Meanwhile, the healthcare sector globally has been resilient, which helped Indian pharma stocks sustain gains. The cautious global backdrop contributed to the overall risk-off mood in Indian equities.

Technical Observations and Outlook

Technically, the Sensex holding above its 50DMA provides some near-term support, but the fact that the 50DMA remains below the 200DMA signals that the broader trend is still under pressure. Investors should watch for confirmation of a sustained recovery or further deterioration in the coming sessions. The strong outperformance of pharma stocks suggests a sectoral rotation towards defensive and growth-oriented themes amid volatility.

Want to dive deeper on ? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!

  • - Real-time research report
  • - Complete fundamental analysis
  • - Peer comparison included

Read the Full Verdict →

Investor Takeaway

Investors should remain cautious amid the prevailing market weakness and sectoral divergences. The metal sector’s sharp decline reflects global demand concerns and could weigh on broader market sentiment if sustained. Conversely, the pharmaceutical sector’s strength offers a defensive play with growth potential. Selective stock picking, focusing on companies with strong fundamentals and positive earnings momentum, remains prudent in the current environment.

Small caps traded largely flat, indicating a lack of conviction among investors in riskier segments. The advance-decline ratio of 0.38x across the BSE500 highlights the dominance of sellers, suggesting that a broader market recovery may require stronger triggers from global markets or domestic economic data.

Overall, the market is navigating a phase of consolidation with pockets of strength in defensive sectors. Monitoring institutional flows and global developments will be key to anticipating the next directional move.

Mojo Stocks - The Top 1% Picks across Markets

Top 10 Large Cap Mid Cap Small Cap
{{col.header}}
Latest
OPEN CALL
CLOSED CALL
{{s[col.key]}} {{s.change_value}}
{{ s.score.value }} - {{ s.score.call_type }}
{{ s.dot_summary.score }} - {{ s.dot_summary.scoreText }}
{{s[col.key]}} {{col.extra}}

Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News